Detection of circulating prostate-specific antigen-positive cells in patients with prostate cancer by flow cytometry and reverse transcription polymerase chain reaction
1996

Detecting PSA-positive Cells in Prostate Cancer Patients

Sample size: 12 publication Evidence: low

Author Information

Author(s): EJ Fadlon, RC Rees, C McIntyre, RM Sharrard, J Lawry, FC Hamdy

Primary Institution: Institute for Cancer Studies, University of Sheffield Medical School

Hypothesis

The study aims to determine whether circulating PSA-positive cells in prostate cancer patients represent tumor cells or other cell types.

Conclusion

The majority of PSA-positive cells detected in the blood of prostate cancer patients do not express PSA mRNA, suggesting they are not tumor cells.

Supporting Evidence

  • 75% of prostate cancer patients had circulating PSA-positive cells detected by flow cytometry.
  • Only 11.1% of those patients expressed PSA mRNA by RT-PCR.
  • The absence of PSA mRNA in most samples suggests that PSA-positive cells are not tumor cells.

Takeaway

Doctors looked for special cells in the blood of men with prostate cancer to see if they were cancer cells, but most of them weren't.

Methodology

The study used flow cytometry and reverse transcription polymerase chain reaction (RT-PCR) to analyze blood samples from prostate cancer patients and controls.

Limitations

The study had a small sample size and did not fully characterize the phenotype of the detected PSA-positive cells.

Participant Demographics

The study included 12 men with newly diagnosed and untreated prostate cancer and 5 control subjects (3 men with benign prostatic hyperplasia and 2 healthy women).

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication